A pill Made in China -- The leap from generic drugs to independent innovation

I can't afford a better medicine

If there are good medicines, the key is to make them available and affordable to the people. Putting the people first and seeking happiness for the Chinese people has never changed the original aspiration of the Communist Party of China.

On June 23, the fifth batch of state-organized drug centralized procurement was opened in Shanghai, with an average price reduction of 56% for 251 products to be selected, which is the largest scale of state-organized drug centralized procurement.

The regular and institutionalized implementation of national drug collection has transformed the advantages of the system into management efficiency, and effectively reduced the burden on patients. Hu Yinglian, a professor at the Party School of the CPC Central Committee (Chinese Academy of Governance), believes that drug governance has changed from being centered on medical treatment in the past to being centered on people's health, with more emphasis on drug quality safety and promoting innovation.

Adhere to the "four aspects" of scientific and technological innovation, including "facing people's life and health". Starting from the urgent and long-term needs of the country, a number of key core technologies in the fields of drugs, medical devices, medical equipment, vaccines and other fields are speeding up breakthroughs.

Looking forward to the "14th Five-Year Plan", it has become a consensus to build a healthy China, deepen the reform of the medical and health system, and lead the high-quality development of the medical field with innovation. The state will also build a TCM science and technology support platform, reform and improve the TCM review and approval mechanism, and promote the development and protection of new TCM drugs and industrial development.